DLBCL treatment after diagnosis: the first treatment plan and response checks

What needs to be known before the first cycle

Ask for a written summary of the subtype, stage and treatment goal. PET-CT commonly maps active lymphoma and provides a baseline for later comparisons. Blood counts, kidney and liver tests, and an assessment of daily function help the team plan treatment intensity. Heart assessment matters when the regimen contains doxorubicin.

The pathology report may include additional molecular tests that change the treatment discussion. If the diagnosis has already been reviewed, the next consultation should focus on the actual regimen and its timing. Bring the report itself, because labels such as double-expressor and double-hit describe different findings.

Sources and references: [1]

Why R-CHOP and Pola-R-CHP may both be discussed

R-CHOP combines rituximab with cyclophosphamide, doxorubicin, vincristine and a steroid. It remains an established initial treatment. Pola-R-CHP replaces vincristine with polatuzumab vedotin and is an option for selected newly diagnosed patients. Suitability depends on risk assessment, the exact lymphoma diagnosis, health and access to the regimen.

A useful question is: what feature of my lymphoma makes this combination the preferred choice? Very frail patients or people with significant heart disease may need an adapted approach. More intensive treatment is not automatically better for every person.

Sources and references: [1]

Turn the regimen into a practical treatment calendar

The number of cycles and any role for radiation depend partly on stage, disease bulk and response. Limited-stage treatment can differ from treatment for disease in several regions. Ask when infusions, oral medicines, blood tests and response scans fall within the plan.

Before treatment starts, discuss fertility preservation if relevant and make a list of prescription medicines and supplements. The team should also plan infection prevention and hepatitis B testing around anti-CD20 treatment. These preparations are easier to organize before the first infusion than during a complication.

Sources and references: [1] [2]

What an early scan can tell you

An interim scan can show how active lymphoma has changed, but an area that lights up on PET can also reflect inflammation. The treating team interprets the images alongside symptoms and the timing of chemotherapy. A concerning result may lead to repeat imaging or a biopsy before a major change.

If you feel a lump shrinking, that is encouraging, but keep the planned assessment. Likewise, fatigue during treatment does not by itself show whether the lymphoma is responding. Ask which findings would actually lead the team to alter your regimen.

Sources and references: [1]

Problems to report between visits

Low blood counts can increase infection and bleeding risks. Nausea, mouth soreness, constipation and numbness in the hands or feet can affect eating and activity. Reporting them early gives the team a chance to adjust supportive medicines or treatment doses.

Get the unit's urgent contact number and its fever instructions in writing. Fever during chemotherapy, shaking chills, new breathlessness or uncontrolled bleeding need urgent medical assessment. If you are receiving care away from home, know which emergency department should see you and carry your current treatment list.

Sources and references: [2]

The decisions after the final cycle

An end-of-treatment assessment checks whether there is a complete metabolic response, residual active disease or another reason for a persistent abnormality. A remaining mass can be scar tissue. If active lymphoma is suspected, confirming the finding may be important before starting further treatment.

When the lymphoma responds, follow-up shifts toward recovery, symptoms and treatment effects. If it persists or returns, the timing and prior treatment help determine whether salvage chemotherapy, transplant, CAR-T or other medicines enter the discussion. Keep copies of the original and final scans for that comparison.

Sources and references: [1]

Prepare a consultation that answers your next decision

Write down the regimen offered, the planned number of cycles and any uncertainty you want resolved. Examples include whether radiation is needed after chemotherapy, how heart disease changes treatment, or what an equivocal PET result means. A focused question helps a second team review the decision efficiently.

Take the pathology report, PET-CT images, recent laboratory results and a dated list of treatment already received. Include serious reactions and dose reductions. A treatment history with exact dates is especially useful when care is moving between hospitals.

Sources and references: [1]

Considering a lymphoma consultation in Shanghai

Ruijin Hospital has hematology services and an international medical service. For confirmed DLBCL, a consultation can focus on the initial regimen or on interpreting response before changing treatment. The DLBCL resource page connects this discussion with related care information.

Contact EastMedGo with the decision you need help arranging and a brief treatment timeline. We can help organize the records requested for a Shanghai consultation, clarify appointment steps and discuss coordination costs. Your existing team can advise how that consultation fits around the next scheduled cycle.

Sources and references: [3]

Common questions